Cordis appoints Christian Spaulding
pharmafile | March 30, 2010 | Appointment | | Cordis, Johnson & Johnson, appointment, research and development
Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs.
He assumes the role, which will see him lead the company’s global clinical strategy, on 1 June and will be based in Paris.
“I’m excited to join Cordis,” said Spaulding. “As an interventional cardiologist, I’ve enjoyed working with the corporation as an investigator. I valued the company’s high quality standards for devices and ethics in clinical research.
“This is a fantastic opportunity to continue innovating with new devices developed by Cordis and have a positive impact on patient outcomes.”
Dr Spaulding is currently director of the Cardiac Catheterization Laboratory at Cochin Hospital and professor of medicine at René Descartes University, both located in Paris, France.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US
Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly …

Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
Johnson & Johnson has submitted a supplemental New Drug Application to the US Food and …






